| 2006 年 | 2007 年 | 2008 年 | 2009 年 | 2010 年 |
| 2011 年 | 2012 年 | 2013 年 | 2014 年 | 2015 年 |
| 2016 年 | 2017 年 | 2018 年 | 2019 年 | 2020 年 |
| 2021 年 | 2022 年 | 2023 年 | 2024 年 |
※ 英文原著論文のみ掲載しています。
【 2020年 】
- Okamoto K, Fujii H, Goto S, Kono K, Watanabe K, Nishi S.
Changes in the whole/intact parathyroid hormone ratio and their clinical implications in patients with chronic kidney disease.
J Nephrol. 2020; 33 (4): 795-802. - Watanabe K, Fujii H, Kono K, Goto S, Nishi S.
Comparison of the effects of lanthanum carbonate and calcium carbonate on the progression of cardiac valvular calcification after initiation of hemodialysis.
BMC Cardiovasc Disord. 2020;20(1):39. - Goto S, Hamano T, Ogata S, Masakane I.
Seasonal variations in cause-specific mortality and transition to renal replacement therapy among patients with end-stage renal disease.
Sci Rep. 2020.11;10(1):2325. - Hyodo T, Kono K, Nishi S, Itoh T, Hara S.
An Incidental Diagnosis of Microscopic Renal Angiomyolipoma Completely Excised on Renal Biopsy: A Case Report.
Am J Case Rep. 2020;21:e921353. - Nishi S, Yamada M, Tsuruya K, Masakane I, Nakamoto H.
JR-131, a biosimilar of darbepoetin alfa, for the treatment of hemodialysis patients with renal anemia: A Randomized, Double-Blinded, Parallel-Group Phase 3 Study.
Ther Apher Dial. 2020; 24 (2): 126-135. - Nishi S, Yamada M, Tsuruya K, Masakane I, Nakamoto H.
Long-term safety and efficacy of JR-131, a biosimilar of darbepoetin alfa, in Japanese patients with renal anemia undergoing hemodialysis: Phase 3 Prospective Study.
Ther Apher Dial. 2020; 24 (2): 136-145. - Fujii H, Kono K, Hara S, Ishimura T, Nishi S.
Histological changes of a kidney in a recipient who received an allograft from a patient with Fabry disease.
J Nephrol. 2020; 33 (4): 657-659. - Furuichi K, Shimizu M, Yamanouchi M, Hoshino J, Sakai N, Iwata Y, Toyama T, Kitajima S, Hara A, Yuzawa Y, Kitamura H, Suzuki Y, Sato H, Uesugi N, Ueda Y, Nishi S, Nishino T, Samejima K, Kohagura K, Shibagaki Y, Makino H, Matsuo S, Ubara Y, Yokoyama H, Wada T.
Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy.
BMJ Open Diabetes Res Care. 8 (1): e001157. - Ito J, Fujii H, Kono K, Goto S, Nishi S.
Pregnant patient on hemodialysis who showed remarkable improvement of severe hyperparathyroidism by strict serum phosphorus control.
Intern Med. 2020; 59(5): 686-694. - Kono K, Fujii H, Watanabe K, Goto S, Nishi S.
Relationship between parathyroid hormone and renin-angiotensin-aldosterone system in hemodialysis patients with secondary hyperparathyroidism.
J Bone Miner Metab. ［Epub ahead of print.］ - Fujii H, Kono K, Watanabe K, Goto S, Nishii T, Kono A, Nishi S.
Evaluation of aortic calcification using a three-dimensional volume-rendering method in patients with end-stage kidney disease.
J Bone Miner Metab. 2020. [Epub ahead of print] - Ito J, Nishi S.
Current Situation of Chronic Kidney Disease Management in General Practice in Japan: A Questionnaire Survey for General Physicians.
Kobe J Med Sci. 65(5):E164-E173, 2020. - Saito K, Fujii H, Kono K, Hirabayashi K, Yamatani S, Watanabe K, Goto S, Komatsu S, Fukumoto T, Nishi S.
Changes in blood pressure during treatment with the tyrosine kinase inhibitor Lenvatinib.
Clin Kidney J. 2020 [Epub ahead of print]. - Watanabe S, Fujii H, Kono K, Watanabe K, Goto S, Nishi S.
Influence of oxidative stress on vascular calcification in the setting of coexisting chronic kidney disease and diabetes mellitus.
Sci Rep. 10(1): 20708, 2020. - Yokoyama H, Yamamoto R, Imai E, Maruyama S, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Fukami K, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Furuichi K, Fujimoto K, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
Better remission rates in elderly Japanese patients with primary membranous nephropathy in nationwide real-world practice: The Japan Nephrotic Syndrome Cohort Study (JNSCS).
Clin Exp Nephrol. 24(10):893-909, 2020. - Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Clin Exp Nephrol. 24(6):526-540, 2020.
